The collaboration, called the Pharmacy Care Reimagined Initiative, aims to reduce prescription drug costs and improve transparency for the insurer’s 5 million health plan members.
The move follows Blue Shield’s decision to sever ties with CVS Health’s Caremark PBM, a change that caused stock prices of major PBMs to drop when it was announced in August 2023.
The new venture is expected to save Blue Shield up to $500 million annually in drug costs, executives involved told Forbes.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
